The Neosartorya fischeri Antifungal Protein 2 (NFAP2): A New Potential Weapon against Multidrug-Resistant Candida auris Biofilms

Minocycline-EDTA-Ethanol Antimicrobial Catheter Lock Solution is highly effective in vitro for Eradication of Candida auris Biofilms

(2020) Ruth A Reitzel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds

(2020) Martin van Eijk et al.   MEDICAL MYCOLOGY

In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris

(2020) Fruzsina Nagy et al.   Frontiers in Microbiology

Efficacy of Ibrexafungerp (SCY-078) Against Candida auris in an In Vivo Guinea Pig Cutaneous Infection Model

(2020) M Ghannoum et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris

(2020) Thayná Lopes Barreto et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Silver Nanoantibiotics Display Strong Antifungal Activity Against the Emergent Multidrug-Resistant Yeast Candida auris Under Both Planktonic and Biofilm Growing Conditions

(2020) Roberto Vazquez-Munoz et al.   Frontiers in Microbiology

Derivates of the Antifungal Peptide Cm-p5 Inhibit Development of Candida auris Biofilms In Vitro

(2020) Dennis Kubiczek et al.   Antibiotics-Basel

Bismuth Nanoantibiotics Display Anticandidal Activity and Disrupt the Biofilm and Cell Morphology of the Emergent Pathogenic Yeast Candida auris

(2020) Roberto Vazquez-Munoz et al.   Antibiotics-Basel

In Vitro Activity of Manogepix against Multidrug-Resistant and Panresistant Candida auris from the New York Outbreak

(2020) YanChun Zhu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cysteine-Rich Antifungal Proteins from Filamentous Fungi are Promising Bioactive Natural Compounds in Anti-Candida Therapy

(2019) László Galgóczy et al.   ISRAEL JOURNAL OF CHEMISTRY

Nitroglycerin-Citrate-Ethanol (NiCE) Catheter Lock Solution is Highly Effective for in vitro Eradication of Candida auris Biofilm

(2019) Nylev Vargas-Cruz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Farnesol increases the activity of echinocandins against Candida auris biofilms

(2019) Fruzsina Nagy et al.   MEDICAL MYCOLOGY

Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs

(2019) David Romera et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Effects of the Natural Peptide Crotamine from a South American Rattlesnake on Candida auris, an Emergent Multidrug Antifungal Resistant Human Pathogen

(2019) Caroline Dal Mas et al.   Biomolecules

In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae

(2019) Zoltán Tóth et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Candida auris outbreak: Mortality, interventions and cost of sustaining control

(2019) Surabhi K Taori et al.   JOURNAL OF INFECTION

Comparison of risk factors and outcomes of Candida auris candidemia with non-Candida auris candidemia: A retrospective study from Pakistan

(2019) Muneeba Ahsan Sayeed et al.   MEDICAL MYCOLOGY

Antifungal Triazole Posaconazole Targets an Early Stage of the Parechovirus A3 Life Cycle

(2019) Eric Rhoden et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro and In Vivo activity of a novel catheter lock solution against bacterial and fungal biofilms

(2018) J Chandra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2)

(2018) Liliána Tóth et al.   Frontiers in Microbiology

Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development

(2018) Gina Wall et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Fungal Cyp51 Specific Inhibitor VT-1598 Demonstrates In vitro and In vivo Activity against Candida auris

(2018) Nathan P. Wiederhold et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vivo applicability of Neosartorya fischeri antifungal protein 2 (NFAP2) in treatment of vulvovaginal candidiasis

(2018) Renátó Kovács et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins

(2017) Andrew M. Borman et al.   MEDICAL MYCOLOGY

Emergence ofCandida auris: An International Call to Arms

(2016) Cornelius J. Clancy et al.   CLINICAL INFECTIOUS DISEASES

Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

(2016) Shawn R. Lockhart et al.   CLINICAL INFECTIOUS DISEASES

Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms

(2016) Renátó Kovács et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Efficacy of anidulafungin in the treatment of experimentalCandida parapsilosiscatheter infection using an antifungal-lock technique

(2016) Jana Basas et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

NFAP2, a novel cysteine-rich anti-yeast protein from Neosartorya fischeri NRRL 181: isolation and characterization

(2016) Liliána Tóth et al.   AMB Express

Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species

(2016) Andrew M. Borman et al.   mSphere

Anti-Candida albicans biofilm effect of novel heterocyclic compounds

(2013) S. Kagan et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris

(2011) Wee Gyo Lee et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter‐Related Infection: 2009 Update by the Infectious Diseases Society of America

(2009) Leonard A. Mermel et al.   CLINICAL INFECTIOUS DISEASES